Genoa Ventures is a venture capital firm that invests in early-stage life sciences technology companies.
Business Model:
Revenue: $0
Employees: 0-0
Address: 3215 21st St
City: San Francisco
State: CA
Zip: 94110
Country: US
Genoa Ventures invests in early-stage life sciences technology companies. They fund entrepreneurs and companies looking to change the way science gets done with new tools and technologies. Sector focus areas include research tools, molecular diagnostics, synthetic biology, and industrial biology. Genoa Ventures was founded in 2014 by Jenny Rooke and is based in San Francisco, California, United States.
Contact Phone:
+14155580050
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2022 | Codetta Biosciences | Series A | 15M |
12/2018 | InterVenn | Venture Round | 0 |
3/2016 | Pivot Bio | Series A | 16M |
8/2021 | InterVenn | Series C | 0 |
1/2017 | Synthomics | Seed Round | - |
6/2015 | Zymergen | Series A | 42.1M |
12/2022 | BrightSpec | Series C | 18.4M |
11/2020 | InterVenn | Series B | 0 |
3/2015 | Caribou Biosciences | Series A | 0 |
1/2014 | Zymergen | Seed Round | 2M |
1/2018 | Ionpath | Series A | - |
7/2021 | BloodQ | Seed Round | 4.5M |
12/2021 | Meiogenix | Series A | 12.4M |
10/2018 | Intabio | Series A | 9.5M |
9/2014 | Zephyrus Biosciences | Seed Round | 1.5M |
10/2021 | SimBioSys | Series A | 0 |
9/2017 | Akadeum Life Sciences | Venture Round | 1.5M |
2/2020 | Intabio | Series B | 18M |
7/2021 | Stemson Therapeutics | Series A | 0 |
9/2017 | Intabio | Seed Round | 2M |
5/2016 | Caribou Biosciences | Series B | 30M |
10/2015 | Ionpath | Seed Round | - |
11/2017 | NanoCellect Biomedical | Series B | 0 |
1/2017 | Adarza BioSystems | Series C | 17M |
9/2022 | ZwitterCo | Series A | 0 |
4/2021 | Attune Neurosciences | Seed Round | 3.8M |
9/2022 | Bond Pet Foods | Series A | 0 |
2/2022 | Epitel | Series A | 0 |
6/2020 | Tropic Biosciences | Series B | 0 |
6/2018 | Mission Bio | Venture Round | - |
12/2020 | BRAINBox Solutions | Series A | 23M |
9/2020 | Ionpath | Series B | 0 |
4/2022 | Codetta Biosciences | Series A | 0 |
2/2022 | Epitel | Series A | 0 |
12/2021 | Meiogenix | Series A | 0 |
10/2021 | SimBioSys | Series A | 0 |
8/2021 | InterVenn | Series C | 0 |
7/2021 | Stemson Therapeutics | Series A | 0 |
7/2021 | BloodQ | Seed Round | 0 |
4/2021 | Attune Neurosciences | Seed Round | 0 |
12/2020 | BRAINBox Solutions | Series A | 0 |
11/2020 | InterVenn | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|